Partnership’s priority is to evaluate mental health medication
etectRx, Inc., a digital health company, announced a signed letter of intent for a novel partnership arrangement with Local Health, Inc., a subsidiary of OneroRx, which operates telepharmacies and community retail pharmacies. The partnership will evaluate patient acceptability of the etectRx FDA-cleared digital pill ID-Cap System, as Local Health will recruit and engage patients, dispense the digital pill system, collect data and publish survey results.
etectRx’s ingestible sensor, the ID-Cap System
The study, which is slated to begin this summer, focuses on mental health medication. Patient participants will evaluate etectRx technology, a system focused on patient empowerment and adherence to treatment regimen. This technology gives Local Health the ability to be involved in real time, assisting patients with remaining adherent to their medication.
etectRx’s and its ID-Cap System have also dabbled in the prescription digital therapeutics (PDTs) space, via an agreement with Pear Therapeutics, Inc. earlier this year that is reportedly the first to explore the use of digital pill solutions with PDTs.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.